A systematic screen for identification of interacting partners of wild-type neurofibromin 2 versus our lipid binding deficient mutant (T59V, W60E, R309Q, R310Q) might reveal additional mechanistic insights into neurofibromin 2 tumor suppressor functions. The gene discussed is NF2; the disease is neoplasm.